In addition, CD8+ T cells were activated independent of the variant peptide pools and CD8+ T cell responses were detected in over 50% of vaccinees and in over 75% of COVID-19 patients against all variants (Figure 3B). This evidence concerns the gene CD8A and COVID-19.